The Exchange had sought clarification from Wockhardt with respect to news appearing in Business Line on May 15, 2015 titled ‘Wockhardt Recalls BP tablets from US.’ Wockhardt replied stating that they would like to state that the Company had already informed the exchange on April 28, 2015 about recall of products. The recall stated in the said article forms part of the same. Further, the Company keeps the exchange informed about events, information etc. including price sensitive information in accordance with regulatory requirements. In present case, they do not have any important information / announcement to be shared. In the event that there is any development that requires disclosure under Clause 36 of the Listing Agreement,they will make the same in accordance with the regulatory requirements.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: